Allergen Immunotherapy Remains Effective

JULY 01, 2005

Patients undergoing a 3-to 5-year course of allergen immunotherapy shots still see the benefits for >5 years after stopping treatment. The findings are based on a survey of immunotherapy patients in Tennessee. The study looked at the return of allergy symptoms in 2 groups of patients—126 had finished immunotherapy 1 to 4 years prior and 167 had completed the regimen 5 to 12 years prior.

"We did not find any major differences in these 2 [groups]—those being off shots 1 to 4 years and those being off shots 5 or more years,"said lead investigator John M. Fahrenholz, MD.

The results of the study showed, in the 1-to 4-year group, that the average symptom scores before immunotherapy, at the completion of immunotherapy, and at present were 8.48, 2.96, and 3.97, respectively. The second group's scores for these time periods were 8.26, 2.94, and 3.95, respectively.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.